NCT03653273 Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03647722 Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab). Status TERMINATED Phase N/A
NCT03637699 A Positive Psychology Intervention for Patients With Multiple Sclerosis Status COMPLETED Phase NA
NCT03636789 Evaluation of the Prevalence of Oculomotor Disorders in Patients With Radiologically Isolated Syndrome Status COMPLETED Phase NA
NCT03632473 Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis Status COMPLETED Phase N/A
NCT03623243 Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients Status COMPLETED Phase PHASE3
NCT03621761 Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue Status COMPLETED Phase PHASE4
NCT03619642 Reliability, Validity and Clinical Utility of a Robotic Assessment for Proprioception Status COMPLETED Phase NA
NCT03610139 Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients Status UNKNOWN Phase NA
NCT03608527 Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis Status COMPLETED Phase NA
NCT03606668 Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders Status COMPLETED Phase NA
NCT03606460 A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS) Status COMPLETED Phase PHASE3
NCT03603691 Study to Evaluate the Reliability and Validity of the Modified Manual Muscle Test for Persons With MS Status COMPLETED Phase NA